MLchartDataset catalogue

BMS-182751

Term · Oncology and biomedicine · MLC-T-ONC-001142

A substance being studied in the treatment of prostate and other types of cancer. It contains the metal platinum and may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called JM 216 and satraplatin.

Table 1. Record
IdentifierMLC-T-ONC-001142
FieldOncology and biomedicine
ExpansionsJM 216; satraplatin
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-001142",
  "term": "BMS-182751",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of prostate and other types of cancer. It contains the metal platinum and may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called JM 216 and satraplatin.",
  "expansions": [
    "JM 216",
    "satraplatin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/bms-182751/"
}

Record 3,693 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.